Results · Apr-Jun 2026
Prism Medico and Pharmacy Q1 FY27 results
Income after interest costs fell 94% against Apr-Jun 2025.
Net profit turned into a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Income after interest costs | 0.1 | 1.6 | −94% |
| Finance costs | 0.0 | 0.0 | n/m |
| Costs & credit losses ÷ income | 164.6% | 59.1% | +105.5 pts |
| Profit | -0.1 | 0.7 | −109% |
| ROA | −1.5% | 16.9% | −18.4 pts |
| ROE | −1.5% | 17.4% | −18.9 pts |
| Borrowings ÷ equity | 0.0% | 0.0% | 0.0 pts |
Standalone figures. Margins & ratios change in percentage points (pts).
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.